Ventas Inc.
VTRBusiness Overview
ticker: VTR step: 01 generated: 2026-05-12 source: quick-research
Ventas Inc. (VTR) — Business Overview
Business Description
Ventas Inc. is a leading S&P 500 healthcare REIT that owns approximately 1,350 properties across North America and the United Kingdom, with a portfolio concentrated in senior housing, outpatient medical buildings, and research & innovation centers. Founded in 1983 and headquartered in Chicago, Illinois, Ventas has strategically repositioned its portfolio over two decades — from 60% skilled nursing in the early 2000s to a diversified mix anchored by Senior Housing Operating Properties (SHOP). The company does not operate its properties directly but rather uses a combination of RIDEA (SHOP) structures and triple-net leases through external operators. FY2024 revenue was $4.9B; FY2025 was $5.8B.
Revenue Model
Ventas generates revenue through two primary lease/operating structures: (1) SHOP (Senior Housing Operating Portfolio) — Ventas owns the asset, a third-party operator (Sunrise, Atria, Revera) manages day-to-day operations, and Ventas captures the residual NOI after operator fees; SHOP represents ~58% of NOI and is subject to occupancy and operating cost variability. (2) Net Leases — tenants (hospitals, health systems, universities) pay fixed rent under triple-net or modified gross leases with annual escalators (typically 2–3%); lower growth but more predictable. Dividends are funded by FFO (Funds From Operations), the REIT-appropriate earnings metric.
Products & Services (Property Segments)
- Senior Housing Operating Portfolio (SHOP) — ~800 communities operated under RIDEA structures; revenue depends on occupancy, daily rates, and payor mix (private-pay dominant)
- Outpatient Medical Buildings (MOB) — ~350 properties leased to health systems, physician groups, and outpatient surgery centers
- Research & Innovation (R&I) — ~30 life science / university research buildings (partnerships with Penn, UChicago, Duke)
- Triple-Net Leases — acute care hospitals, skilled nursing facilities, and health system campuses under long-term net leases
Customer Base & Go-to-Market
Ventas's "customers" are primarily residents of senior housing communities (private-pay, 85%+) and tenants in MOB/R&I buildings (health systems, universities, research institutions). Private-pay senior housing is not subject to government reimbursement risk. Major SHOP operators include Sunrise Senior Living, Atria Senior Living, and Ardent Health. Long-term lease relationships with major health systems (Advocate Aurora, Tenet) provide stable base cash flows.
Competitive Position
Ventas is the #2 healthcare REIT by market cap behind Welltower (WELL). The company differentiates through its premier operator relationships, research-adjacent real estate (R&I buildings near top-tier universities), and investment scale — deploying $2B+ in senior housing acquisitions in 2024 and raising 2026 investment guidance to $3B. The structural demographic tailwind (baby boomers entering peak senior housing need years) is the single largest long-term driver for the entire healthcare REIT sector through 2035.
Key Facts
- Founded: 1983
- Headquarters: Chicago, Illinois
- Employees: ~500 (lean REIT structure; operators employ separately)
- Exchange: NYSE
- Sector / Industry: Real Estate / Healthcare REITs
- Market Cap: ~$20–25B
Financial Snapshot
ticker: VTR step: 04 generated: 2026-05-12 source: quick-research
Ventas Inc. (VTR) — Financial Snapshot
Note: For REITs, FFO (Funds From Operations) and Normalized FFO are the primary earnings metrics. GAAP net income shows losses due to real estate depreciation — this is normal for REITs.
Income Statement Summary
| Metric | FY2022 | FY2023 | FY2024 | YoY |
|---|---|---|---|---|
| Revenue | $4.13B | $4.50B | $4.92B | +9.5% |
| Net Operating Income (NOI) | ~$1.8B | ~$2.0B | ~$2.3B | +~15% |
| GAAP Net Income (Loss) / share | ($0.12) | ($0.10) | ~$0.05 | +flip |
| Normalized FFO / share | ~$2.80 | $2.99 | $3.19 | +6.7% |
| SHOP Same-Store NOI Growth | ~8% | ~16% | ~15.8% | — |
FY2025: Revenue $5.82B (+19%); Normalized FFO ~$3.44/share (8% growth). FY2026: 5th consecutive year of double-digit SHOP same-store NOI growth projected.
Cash Flow & Balance Sheet (FY2024)
| Metric | Value |
|---|---|
| Operating Cash Flow | ~$1.5B |
| FFO (total) | ~$1.5B |
| Dividends Paid | ~$1.3B |
| Total Debt | ~$14B |
| Debt / Total Assets | ~40% |
Key Ratios (approximate)
- Price / FFO: ~18–20x | Dividend Yield: ~3.5–4% | EV/EBITDA: ~22x
- SHOP Avg Occupancy (Q1 2026): 88.6% (+240bp YoY) vs. stabilized ~93%
- Revenue Growth (FY2024): +9.5% | FFO/share Growth: +6.7%
Growth Profile
Ventas has delivered three consecutive years of 15–16% SHOP same-store NOI growth, driven by occupancy recovery post-COVID and robust demand from aging demographics. The SHOP model creates significant operating leverage — each 100bp of occupancy improvement translates to ~3–4% NOI growth as incremental revenue flows through with minimal marginal cost. FFO per share has grown from ~$2.80 in FY2022 to ~$3.44 in FY2025. Management raised FY2026 investment guidance to $3B, targeting accretive senior housing acquisitions where buying is more attractive than new construction.
Forward Estimates
- FY2026 Normalized FFO: ~$3.65–3.75/share (~8% growth guidance)
- SHOP same-store NOI growth: double-digit for 5th consecutive year
- Total company same-store NOI growth: ~6.75% midpoint
- Analyst price target consensus: ~$93.56 (P/S ratio ~7x vs. ~5.5x sector avg)
Deeper Financial Analysis
The fundamental tier adds 9 additional research dimensions for $VTR.